{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T14:27:57Z","timestamp":1791556077777,"version":"4.3.4"},"reference-count":70,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.schres.2010.09.014","type":"journal-article","created":{"date-parts":[[2010,10,14]],"date-time":"2010-10-14T10:00:52Z","timestamp":1287050452000},"page":"13-21","source":"Crossref","is-referenced-by-count":193,"title":["Peripheral oxytocin is associated with reduced symptom severity in schizophrenia"],"prefix":"10.1016","volume":"124","author":[{"given":"Leah H.","family":"Rubin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Sue","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Drogos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossein","family":"Pournajafi-Nazarloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline M.","family":"Maki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2010.09.014_bb0005","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/1073858403252674","article-title":"Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia","volume":"9","author":"Abi-Dargham","year":"2003","journal-title":"Neuroscientist"},{"key":"10.1016\/j.schres.2010.09.014_bb0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0278-5846(03)00161-1","article-title":"Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial","volume":"27","author":"Akhondzadeh","year":"2003","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0015","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.schres.2006.02.008","article-title":"Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia","volume":"84","author":"Akhondzadeh","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0020","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1001\/archinte.158.17.1855","article-title":"Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults","volume":"158","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.schres.2010.09.014_bb0025","first-page":"37","article-title":"Psychotropic properties of oxytocin","volume":"30","author":"Bakharev","year":"1984","journal-title":"Probl. Endokrinol. (Mosk)"},{"key":"10.1016\/j.schres.2010.09.014_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0306-4530(85)90056-3","article-title":"Vasopressin\u2013oxytocin in cerebrospinal fluid of schizophrenic patients and normal controls","volume":"10","author":"Beckmann","year":"1985","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0035","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.schres.2004.06.013","article-title":"Plasma concentrations of estradiol in women suffering from schizophrenia treated with conventional versus atypical antipsychotics","volume":"73","author":"Bergemann","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0040","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2004.12.009","article-title":"Estrogen as an adjuvant therapy to antipsychotics does not prevent relapse in women suffering from schizophrenia: results of a placebo-controlled double-blind study","volume":"74","author":"Bergemann","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0045","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1017\/S0033291707000578","article-title":"Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia","volume":"37","author":"Bergemann","year":"2007","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2010.09.014_bb0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1210\/jc.2008-1902","article-title":"The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men","volume":"94","author":"Brambilla","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.schres.2010.09.014_bb0055","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/bmj.4.5835.298-c","article-title":"Hormones in the treatment of psychoses","volume":"4","author":"Bujanow","year":"1972","journal-title":"Br. Med. J."},{"key":"10.1016\/j.schres.2010.09.014_bb0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.mp.4002150","article-title":"Oxytocin as a natural antipsychotic: a study using oxytocin knockout mice","volume":"14","author":"Caldwell","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0065","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1196\/annals.1384.006","article-title":"Oxytocin: behavioral associations and potential as a salivary biomarker","volume":"1098","author":"Carter","year":"2007","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.schres.2010.09.014_bb0070","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0079-6123(08)00427-5","article-title":"Oxytocin, vasopressin and sociality","volume":"170","author":"Carter","year":"2008","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0075","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1097\/00006842-200109000-00016","article-title":"Changes in premenstrual symptoms in women with schizophrenia: a prospective study","volume":"63","author":"Choi","year":"2001","journal-title":"Psychosom. Med."},{"key":"10.1016\/j.schres.2010.09.014_bb0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.schres.2010.03.040","article-title":"Effect of aripiprazole versus haloperidol on PANSS Prosocial items in early-episode patients with schizophrenia","volume":"120","author":"Docherty","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s002130050811","article-title":"Oxytocin modulates psychotomimetic-induced deficits in sensorimotor gating","volume":"141","author":"Feifel","year":"1999","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2010.09.014_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2010.04.039","article-title":"Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients","author":"Feifel","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0095","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-P)","author":"First","year":"1995"},{"key":"10.1016\/j.schres.2010.09.014_bb0100","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0920-9964(94)90021-3","article-title":"Cerebrospinal fluid oxytocin concentration in schizophrenic patients does not differ from control subjects and is not changed by neuroleptic medication","volume":"11","author":"Glovinsky","year":"1994","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.schres.2007.09.019","article-title":"Diminished plasma oxytocin in schizophrenic patients with neuroendocrine dysfunction and emotional deficits","volume":"98","author":"Goldman","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0110","first-page":"4476","article-title":"Associations among oral estrogen use, free testosterone concentration, and lean body mass among postmenopausal women","volume":"85","author":"Gower","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.schres.2010.09.014_bb0115","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1196\/annals.1314.042","article-title":"Negative correlation between negative symptoms of schizophrenia and testosterone levels","volume":"1032","author":"Goyal","year":"2004","journal-title":"Ann. NY Acad. Sci."},{"issue":"Suppl 2","key":"10.1016\/j.schres.2010.09.014_bb0120","first-page":"1","article-title":"Hormonal aspects of schizophrenias: an overview","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0125","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0006-3223(93)90141-Y","article-title":"Variation in symptom severity over the menstrual cycle of schizophrenics","volume":"33","author":"Hallonquist","year":"1993","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0920-9964(97)00073-X","article-title":"Menstrually related symptom changes in women with schizophrenia","volume":"27","author":"Harris","year":"1997","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0135","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.yfrne.2009.05.005","article-title":"Oxytocin, vasopressin, and human social behavior","volume":"30","author":"Heinrichs","year":"2009","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.schres.2010.09.014_bb0140","doi-asserted-by":"crossref","first-page":"361","DOI":"10.4088\/JCP.v68n0302","article-title":"Sexual function and gonadal hormones in patients taking antipsychotic treatment for schizophrenia or schizoaffective disorder","volume":"68","author":"Howes","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0145","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1600-0447.2003.00251.x","article-title":"Psychotic disorders and gonadal function: evidence supporting the oestrogen hypothesis","volume":"109","author":"Huber","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2010.09.014_bb0150","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.psyneuen.2004.05.010","article-title":"Sex hormones in psychotic men","volume":"30","author":"Huber","year":"2005","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0155","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.fertnstert.2004.03.056","article-title":"Body mass index in relation to semen quality and reproductive hormones among 1558 Danish men","volume":"82","author":"Jensen","year":"2004","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.schres.2010.09.014_bb0160","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The Positive and Negative Syndrome Scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2010.09.014_bb0165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/17470910802319710","article-title":"Sharing secrets: oxytocin and trust in schizophrenia","volume":"4","author":"Keri","year":"2009","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.schres.2010.09.014_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/13651500500526235","article-title":"Effect of hormone replacement therapy on cognitive function in women with chronic schizophrenia","volume":"10","author":"Ko","year":"2006","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.schres.2010.09.014_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2007.02.002","article-title":"Association between serum testosterone levels and the severity of negative symptoms in male patients with chronic schizophrenia","author":"Ko","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/JCP.0b013e31817d5912","article-title":"Short-term testosterone augmentation in male schizophrenics: a randomized, double-blind, placebo-controlled trial","volume":"28","author":"Ko","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.schres.2010.09.014_bb0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.psyneuen.2008.08.015","article-title":"Effect of risperidone and olanzapine on reproductive hormones, psychopathology and sexual functioning in male patients with schizophrenia","volume":"34","author":"Konarzewska","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nature03701","article-title":"Oxytocin increases trust in humans","volume":"435","author":"Kosfeld","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.schres.2010.09.014_bb0195","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00737-002-0001-5","article-title":"A clinical trial of adjunctive oestrogen treatment in women with schizophrenia","volume":"5","author":"Kulkarni","year":"2002","journal-title":"Arch. Womens Ment. Health"},{"key":"10.1016\/j.schres.2010.09.014_bb0200","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/archpsyc.65.8.955","article-title":"Estrogen in severe mental illness: a potential new treatment approach","volume":"65","author":"Kulkarni","year":"2008","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0205","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yfrne.2004.05.001","article-title":"Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication","volume":"25","author":"Landgraf","year":"2004","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.schres.2010.09.014_bb0210","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/sj.npp.1300722","article-title":"Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin","volume":"30","author":"Lee","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2010.09.014_bb0215","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0306-4530(92)90019-4","article-title":"Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics","volume":"17","author":"Legros","year":"1992","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0220","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/oxfordjournals.schbul.a007071","article-title":"The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003","volume":"30","author":"Lehman","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2010.09.014_bb0225","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/09513590802306218","article-title":"Reproductive hormones in plasma over the menstrual cycle in primary dysmenorrhea compared with healthy subjects","volume":"24","author":"Liedman","year":"2008","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.schres.2010.09.014_bb0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/BF00461555","article-title":"Cerebrospinal fluid neurophysins in affective illness and in schizophrenia","volume":"234","author":"Linkowski","year":"1984","journal-title":"Eur. Arch. Psychiatry Neurol. Sci."},{"key":"10.1016\/j.schres.2010.09.014_bb0235","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1017\/S1092852900009342","article-title":"Improvement in prosocial functioning after a switch to ziprasidone treatment","volume":"9","author":"Loebel","year":"2004","journal-title":"CNS Spectr."},{"key":"10.1016\/j.schres.2010.09.014_bb0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-9964(03)00082-3","article-title":"Conjugated estrogens as adjuvant therapy in the treatment of acute schizophrenia: a double-blind study","volume":"66","author":"Louza","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0245","first-page":"133","article-title":"Morphometric evaluation of neurophysin-immunoreactivity in the human brain: pronounced inter-individual variability and evidence for altered staining patterns in schizophrenia","volume":"34","author":"Mai","year":"1993","journal-title":"J. Hirnforsch."},{"key":"10.1016\/j.schres.2010.09.014_bb0250","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/npp.2009.26","article-title":"Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia","volume":"34","author":"Marx","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.schres.2010.09.014_bb0255","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0306-4530(94)90017-5","article-title":"Serum gonadal steroid hormones in young schizophrenic patients","volume":"19","author":"Oades","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0260","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.psychres.2009.09.017","article-title":"Preliminary evidence that plasma oxytocin levels are elevated in major depression","volume":"178","author":"Parker","year":"2010","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0265","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2826.2003.01061.x","article-title":"Oxytocin, but not oxytocin receptor, is rRegulated by oestrogen receptor beta in the female mouse hypothalamus","volume":"15","author":"Patisaul","year":"2003","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.schres.2010.09.014_bb0270","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00005053-200010000-00003","article-title":"Assessing positive and negative symptoms in outpatients with schizophrenia and mood disorders","volume":"188","author":"Purnine","year":"2000","journal-title":"J. Nerv. Ment. Dis."},{"issue":"Suppl 2","key":"10.1016\/j.schres.2010.09.014_bb0275","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0306-4530(02)00126-9","article-title":"Effects of estrogen on brain development and neuroprotection\u2013implications for negative symptoms in schizophrenia","volume":"28","author":"Rao","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0280","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1034\/j.1600-0447.2000.00011.x","article-title":"Gender aspects in schizophrenia: bridging the border between social and biological psychiatry","author":"Riecher-Rossler","year":"2000","journal-title":"Acta Psychiatr. Scand. Suppl."},{"key":"10.1016\/j.schres.2010.09.014_bb0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/schbul\/20.1.203","article-title":"Can estradiol modulate schizophrenic symptomatology?","volume":"20","author":"Riecher-Rossler","year":"1994","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2010.09.014_bb0290","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.09m05031yel","article-title":"Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder: an 8-week, double-blind, randomized, controlled, 2-center, parallel-group trial","author":"Ritsner","year":"2010","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0295","article-title":"Oxytocin, dopamine, and the amygdala: a neurofunctional model of social cognitive deficits in schizophrenia","author":"Rosenfeld","year":"2010","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2010.09.014_bb0300","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.yhbeh.2004.10.002","article-title":"Menstrual cycle-related changes in plasma oxytocin are relevant to normal sexual function in healthy women","volume":"47","author":"Salonia","year":"2005","journal-title":"Horm. Behav."},{"key":"10.1016\/j.schres.2010.09.014_bb0305","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0306-4530(94)90062-0","article-title":"Role of oxytocin in the neuroadaptation to drugs of abuse","volume":"19","author":"Sarnyai","year":"1994","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2007.01.009","article-title":"Plasma oxytocin levels and anxiety in patients with major depression","author":"Scantamburlo","year":"2007","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.schres.2010.09.014_bb0315","doi-asserted-by":"crossref","unstructured":"Shahrokh, D. K., Zhang, T. Y., Diorio, J., Gratton, A.Meaney, M. J., Oxytocin-dopamine interactions mediate variations in maternal behavior in the rat. Endocrinology. 151, 2276-2286.","DOI":"10.1210\/en.2009-1271"},{"key":"10.1016\/j.schres.2010.09.014_bb0320","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.yhbeh.2009.03.019","article-title":"Oxytocin and social perception: oxytocin increases perceived facial trustworthiness and attractiveness","volume":"56","author":"Theodoridou","year":"2009","journal-title":"Horm. Behav."},{"key":"10.1016\/j.schres.2010.09.014_bb0325","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0165-1781(00)00161-X","article-title":"Estrogen affects cognition in women with psychosis","volume":"94","author":"Thompson","year":"2000","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2010.09.014_bb0330","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/BF02247726","article-title":"Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats","volume":"109","author":"Uvnas-Moberg","year":"1992","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.schres.2010.09.014_bb0335","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4088\/JCP.v64n0607","article-title":"Chlorpromazine equivalent doses for the newer atypical antipsychotics","volume":"64","author":"Woods","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2010.09.014_bb0340","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00001756-199803300-00031","article-title":"Estrogen receptor alpha is essential for induction of oxytocin receptor by estrogen","volume":"9","author":"Young","year":"1998","journal-title":"NeuroReport"},{"key":"10.1016\/j.schres.2010.09.014_bb0345","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yhbeh.2005.07.009","article-title":"Oxytocin is associated with human trustworthiness","volume":"48","author":"Zak","year":"2005","journal-title":"Horm. Behav."},{"key":"10.1016\/j.schres.2010.09.014_bb0350","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1210\/jcem-71-4-929","article-title":"Plasma free and non-sex-hormone-binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity","volume":"71","author":"Zumoff","year":"1990","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410015434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996410015434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,5]],"date-time":"2019-06-05T13:13:43Z","timestamp":1559740423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996410015434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":70,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0920996410015434"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2010.09.014","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}